EXPERT OPINION ON THERAPEUTIC PATENTS

Journal website Submission website

Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.

Journal Title

EXPERT OPIN THER PAT

ISSN / eISSN

1354-3776 / 1744-7674

Aims and Scope

Expert Opinion on Therapeutic Patents (ISSN 1354-3776 [print], 1744-7674 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on recent pharmaceutical patent claims, providing expert opinion the scope for future development, in the context of the scientific literature.

The Editors welcome:

Reviews covering recent patent claims on compounds or applications with therapeutic potential, including biotherapeutics and small-molecule agents with specific molecular targets; and patenting trends in a particular therapeutic area
Patent Evaluations examining the aims and chemical and biological claims of individual patents
Perspectives on issues relating to intellectual property
The audience consists of scientists, managers and decision-makers in the pharmaceutical industry and others closely involved in R&D
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days.

Subject Area

CHEMISTRY, MEDICINAL

PHARMACOLOGY & PHARMACY

CiteScore

11.30

View Trend

CiteScore Ranking

Category	Quartile	Rank
Pharmacology, Toxicology and Pharmaceutics - Pharmacology	Q1	#27/301
Pharmacology, Toxicology and Pharmaceutics - Drug Discovery	Q1	#17/156

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2023)	Quartile
CHEMISTRY, MEDICINAL - SCIE	Q1
PHARMACOLOGY & PHARMACY - SCIE	Q1

H-index

Country/Area of Publication

ENGLAND

Publisher

Taylor and Francis Ltd.

Publication Frequency

Monthly

Year Publication Started

1994

Annual Article Volume

Open Access

Contact

INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON, ENGLAND, EC2A 4LQ

Popular journals in the same field
Recent articles

Conjugates of monocyclic β-lactams and siderophore mimetics: a patent evaluation (WO2023023393): (2023) Alen Krajnc, Stanislav Gobec

N-acetylgalactosamine delivery systems for RNA therapeutics:a patent perspective: (2023) Hai-Long Zhang, Lansuo Wang

The next generation of EGFR inhibitors: a patenting perspective of PROTACs based EGFR degraders: (2023) Pengyun Li, Bingkun Li, Ning Yang, Tingting Xu, Zhibing Zheng

An updated patent review of GLP-1 receptor agonists (2020-present): (2023) Weiwen Lu, Zhongbo Zhou, Neng Jiang, Jing Han

An updated patent review of AKT inhibitors (2020 – present): (2023) Linjie Li, Yu Guo, Yang Lu, Yaping Xu, Yan Lu, Xiuping Zhu, Xiaowu Dong, Jinxin Che

G-quadruplexes in cancer-related gene promoters: from identification to therapeutic targeting: (2023) Francesca Romano, Anna Di Porzio, Nunzia Iaccarino, Gelsomina Riccardi, Ritamaria Di Lorenzo, Sonia Laneri, Bruno Pagano, Jussara Amato, Antonio Randa...

Proteasome inhibitors as anticancer agents: (2023) Giorgia Gazzaroli, Andrea Angeli, Arianna Giacomini, Roberto Ronca

Therapeutic treatment strategies for the management of onychomycosis: a patent perspective: (2023) Snigdha Chakraborty, Sanshita, Inderbir Singh

Natural products as a source of new anticancer chemotypes: (2023) Francesco Melfi, Simone Carradori, Noemi Mencarelli, Cristina Campestre, Marialucia Gallorini, Silvia Di Giacomo, Antonella Di Sotto

CDC7 kinase inhibitors: a survey of recent patent literature (2017–2022): (2023) Takayuki Irie, Masaaki Sawa

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More